Gina m. denicola
Deparment of Cancer Imaging and Metabolism
Moffitt Cancer Center
United States of America
Dr. Gina M. DeNicola is affiliated to Deparment of Cancer Imaging and Metabolism, Moffitt Cancer Center. Dr. Gina M. DeNicola is currently providing services as Researcher. Dr. Gina M. DeNicola has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Gina M. DeNicola contributions have acclaimed recognition from honourable subject experts around the world. Dr. Gina M. DeNicola is actively associated with different societies and academies. Dr. Gina M. DeNicola academic career is decorated with several reputed awards and funding. Dr. Gina M. DeNicola research interests include A major research focus of her lab is investigating how NRF2 promotes tumorigenesis and metabolic deregulation in vivo using genetically engineered mouse model systems. .
A major research focus of her lab is investigating how NRF2 promotes tumorigenesis and metabolic deregulation in vivo using genetically engineered mouse model systems.
Chio II, Jafarnejad SM, Ponz-Sarvise M, Park Y, Rivera K, Palm W, Wilson J, Sangar V, Hao Y, Öhlund D, Wright K. NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer. Cell. 2016 Aug 11;166(4):963-76.
Mullarky E, Lucki NC, Zavareh RB, Anglin JL, Gomes AP, Nicolay BN, Wong JC, Christen S, Takahashi H, Singh PK, Blenis J. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers. Proceedings of the National Academy of Sciences. 2016 Feb 16;113(7):1778-83.
Moon JS, Nakahira K, Chung KP, DeNicola GM, Koo MJ, Pabón MA, Rooney KT, Yoon JH, Ryter SW, Stout-Delgado H, Choi AM. NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages. Nature medicine. 2016 Sep;22(9):1002.